Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1.26	2.55	2.02	2.28	2.49	1.77
Short-Term Investments	-	-	-	-	-	27.93
Cash & Short-Term Investments	1.26	2.55	2.02	2.28	2.49	29.7
Cash Growth	-16.61%	26.03%	-11.32%	-8.36%	-91.63%	-44.23%
Receivables	4.99	5.52	0.38	1.04	0.2	2.15
Inventory	1.61	1.71	2.38	4.39	7.09	7.97
Prepaid Expenses	0.53	1.13	1.07	0.99	0.84	1.4
Other Current Assets	0.82	0.6	0.45	0.39	0.64	-
Total Current Assets	9.2	11.51	6.29	9.09	11.26	41.22
Property, Plant & Equipment	1.77	2.4	2.87	3.63	4.19	4.63
Long-Term Investments	16.06	20.98	38.8	43.72	43.79	13.33
Other Long-Term Assets	0.31	0.3	0.26	0.3	0.3	0.29
Total Assets	27.34	35.18	48.23	56.73	59.54	59.46
Accounts Payable	0.58	1.29	0.3	0.26	0.52	0.02
Accrued Expenses	22.63	18.59	14.45	8.93	6.94	11.48
Short-Term Debt	10.69	11.34	9.18	3.6	5.52	4.54
Current Portion of Long-Term Debt	16.21	16.38	14.66	10.16	5.48	10.01
Current Portion of Leases	2.33	0.87	0.7	0.74	1.14	0.99
Current Unearned Revenue	-	10	10	-	-	-
Other Current Liabilities	11.7	3.04	5.04	13.41	3.78	5.79
Total Current Liabilities	64.13	61.51	54.32	37.1	23.38	32.83
Long-Term Debt	2.24	2.23	3.73	4.65	3.37	-
Long-Term Leases	1.08	1.84	2.55	3.26	3.47	3.93
Long-Term Unearned Revenue	-	-	-	10	10	10.5
Other Long-Term Liabilities	13.68	17.36	21.71	23.17	24.47	23.25
Total Liabilities	81.12	82.94	82.32	78.18	64.69	70.51
Common Stock	0.06	0.06	0.05	0.05	0.05	0.05
Additional Paid-In Capital	225.87	225.33	220.82	220.02	218.73	215.21
Retained Earnings	-260.83	-256.12	-252.34	-241.27	-225.08	-226.23
Comprehensive Income & Other	-18.89	-17.03	-2.62	-0.26	1.14	-0.08
Shareholders' Equity	-53.78	-47.76	-34.09	-21.45	-5.16	-11.05
Total Liabilities & Equity	27.34	35.18	48.23	56.73	59.54	59.46
Total Debt	32.54	32.65	30.82	22.41	18.99	19.48
Net Cash (Debt)	-31.28	-30.1	-28.8	-20.13	-16.5	10.22
Net Cash Growth	-	-	-	-	-	-33.13%
Net Cash Per Share	-0.51	-0.57	-0.58	-0.41	-0.34	0.24
Filing Date Shares Outstanding	63.87	61.85	50.93	49.31	49.31	48.99
Total Common Shares Outstanding	63.87	61.85	49.58	49.31	48.99	48.47
Working Capital	-54.93	-50	-48.03	-28.01	-12.13	8.39
Book Value Per Share	-0.84	-0.77	-0.69	-0.43	-0.11	-0.23
Tangible Book Value	-53.78	-47.76	-34.09	-21.45	-5.16	-11.05
Tangible Book Value Per Share	-0.84	-0.77	-0.69	-0.43	-0.11	-0.23
Machinery	0.49	0.48	0.47	0.45	0.45	0.43
Construction In Progress	-	-	-	0.06	-	-
Leasehold Improvements	0.04	0.04	0.04	0.04	0.04	0.08

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.